Day One concludes patient enrolment for tovorafenib’s FIREFLY-2 trialWorldPharmaceuticals·May 11 at 04:39 AMDAWN0.00%
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 1-Year High - What's Next?Market Beat·Apr 20 at 12:59 PMDAWN0.00%
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?Unusual Whales·Apr 9 at 02:31 PMDAWN0.00%BIB-3.98%
JonesTrading Sticks to Its Hold Rating for Day One Biopharmaceuticals (DAWN)Tip Ranks·Apr 6 at 03:40 PMDAWN0.00%
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 20.3% in MarchMarket Beat·Mar 30 at 01:50 AMDAWN0.00%
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? | SEM Stock NewsStockTitan·Mar 26 at 08:50 PMSBIO-2.46%XBI-2.83%
Algert Global LLC Buys 411,000 Shares of Day One Biopharmaceuticals, Inc. $DAWNMarket Beat·Mar 17 at 02:09 AMDAWN0.00%
Weekly Buzz: BMY Wins FDA Nod; EU Okays JNJ's AKEEGA; IPSEY Withdraws Tazverik, DAWN Acquiredrttnews·Mar 13 at 09:17 AMJNJ+0.77%DAWN0.00%
Are DAWN, TALK, UNF Obtaining Fair Deals for their Shareholders? | UNF Stock NewsStockTitan·Mar 12 at 04:55 AMXHS-0.81%IHF-0.29%
